Chemotherapy-free regimens in frontline follicular lymphoma

被引：0
|
作者：
Batlevi, Connie Lee [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 139卷 / 15期
关键词：
LENALIDOMIDE;
D O I：
10.1182/blood.2021015120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Lenalidomide and anti-CD20-based combinations have validated efficacy in treatment of follicular lymphoma in both the frontline and the relapsed settings. In this issue of Blood, Bachy et al(1) report the tolerability and efficacy of obinutuzumab and lenalidomide in the frontline therapy of follicular lymphoma.
引用
收藏
页码：2263 / 2264
页数：3
相关论文
共 50 条
  • [21] Novel Therapies in Mantle Cell Lymphoma: A Pathway to Chemotherapy-Free Strategies
    Nastoupil, Loretta J.
    Koff, Jean L.
    Flowers, Christopher R.
    ONCOLOGY-NEW YORK, 2013, 27 : 8 - 12
  • [22] Chemotherapy Sensitivity for Recurrent Small-Cell Lung Cancer Based on Chemotherapy-Free Interval and Treatment Regimens
    Akazawa, Y.
    Kubota, A.
    Mihashi, Y.
    Yano, Y.
    Mori, M.
    Uchida, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S668 - S669
  • [23] Long-term efficacy and safety of chemotherapy-free first-line iodine-131-rituximab radioimmunotherapy of follicular lymphoma
    Kesavan, Murali
    Zammar, Ghassan
    McQuillan, James T.
    Macdonald, William B. G.
    Turner, J. Harvey
    McQuillan, Andrew D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (01) : 237 - 241
  • [24] Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
    Schmidt, Christian
    Zoellner, Anna-Katharina
    Jurinovic, Vindi
    Soekler, Martin
    Forstpointner, Roswitha
    Haubner, Sascha
    Buske, Christian
    Viardot, Andreas
    Keller, Ulrich
    Pott, Christiane
    Graeven, Ullrich
    Marks, Reinhard
    Haenel, Mathias
    Liersch, Ruediger
    Duerig, Jan
    Hoster, Eva
    Unterhalt, Michael
    Hiddemann, Wolfgang
    BLOOD, 2018, 132
  • [25] Chemotherapy-free treatment in non-Hodgkin lymphoma: a steep learning curve
    Reagan, Patrick M.
    Barr, Paul M.
    LANCET HAEMATOLOGY, 2017, 4 (04): : E152 - E153
  • [26] Revolutionary changes in salvage treatment for Hodgkin lymphoma: toward a chemotherapy-free future
    Chen, Jiawen
    Yang, Wei
    Gong, Zimu
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
  • [27] Immune checkpoint inhibition: chemotherapy-free regimens & new PD-1 inhibitors on the horizon
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (SUPPL 5) : S112 - S116
  • [28] Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)
    Moccia, Alden Alberto
    Schaer, Saemi
    Hayoz, Stefanie
    Pirosa, Maria Cristina
    Taverna, Christian
    Novak, Urban
    Kimby, Eva
    Ghielmini, Michele
    Zucca, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (06) : 1031 - 1034
  • [29] Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study
    Askeland, Georgina
    IMMUNOTHERAPY, 2013, 5 (05) : 447 - 447
  • [30] Rituximab chemotherapy regimens for treating advanced follicular lymphoma evaluated in new study
    Askeland, Georgina
    FUTURE ONCOLOGY, 2013, 9 (05) : 631 - 632
12345